131 related articles for article (PubMed ID: 579835)
1. [Local proteinase inhibitor concentration in uterine secretions with intrauterine spirals (IUD) in situ (proceedings)].
Tauber PF; Herting W; Kurz E; Feichter GE
Arch Gynakol; 1977 Jul; 224(1-4):32-3. PubMed ID: 579835
[TBL] [Abstract][Full Text] [Related]
2. Postpartum IUDS: keys for success.
O'Hanley K; Huber DH
Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine contraceptive devices. Complications associated with their use.
Nagel TC
Postgrad Med; 1983 Mar; 73(3):155-64. PubMed ID: 6828391
[TBL] [Abstract][Full Text] [Related]
4. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
5. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
Clark DA; Wang S; Rogers P; Vince G; Affandi B
Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
[TBL] [Abstract][Full Text] [Related]
6. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
7. Effect of prior pregnancy and combined oral contraceptives on baseline menstrual blood loss and bleeding response to intrauterine devices.
Andrade AT; de Souza JP; Rowe PJ; Shaw ST
Contraception; 1979 Jul; 20(1):19-26. PubMed ID: 477314
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
Hasson HM; Berger GS; Edelman DA
Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 24 patients with IUD-related problems: hysteroscopic findings.
Tadesse E; Wamsteker K
Eur J Obstet Gynecol Reprod Biol; 1985 Jan; 19(1):37-41. PubMed ID: 3979653
[TBL] [Abstract][Full Text] [Related]
10. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
[TBL] [Abstract][Full Text] [Related]
11. Intrauterine contraception.
Reinprayoon D
Curr Opin Obstet Gynecol; 1992 Aug; 4(4):527-30. PubMed ID: 1324024
[TBL] [Abstract][Full Text] [Related]
12. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
13. Effect of the intrauterine contraceptive device on protein components of human uterine fluid.
Tauber PF; Cramer GM; Zaneveld LJ
Contraception; 1993 Nov; 48(5):494-512. PubMed ID: 8275697
[TBL] [Abstract][Full Text] [Related]
14. Quantitative studies on menstrual blood loss in IUD users.
Andrade AT; Pizarro Orchard E
Contraception; 1987 Jul; 36(1):129-44. PubMed ID: 3311622
[TBL] [Abstract][Full Text] [Related]
15. A review of the use of intrauterine devices in nulliparous women.
Graham S; Simcock BW
Contraception; 1982 Oct; 26(4):323-46. PubMed ID: 6759026
[TBL] [Abstract][Full Text] [Related]
16. Endometrial morphological changes in IUD users: a review.
Sheppard BL
Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
[TBL] [Abstract][Full Text] [Related]
17. The effect of intrauterine devices containing zinc and copper on their levels in serum.
Anteby SO; Bassat HA; Yarkoni S; Aboulafia Y; Sadovsky E
Fertil Steril; 1978 Jan; 29(1):30-4. PubMed ID: 620840
[TBL] [Abstract][Full Text] [Related]
18. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
Sheppard BL; Bonnar J
Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
[TBL] [Abstract][Full Text] [Related]
19. [Intrauterine contraceptive devices. Mode of action, experiences, complications (author's transl)].
Ludwig H
Geburtshilfe Frauenheilkd; 1976 Feb; 36(2):97-108. PubMed ID: 943359
[TBL] [Abstract][Full Text] [Related]
20. Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion.
Howard B; Grubb E; Lage MJ; Tang B
Reprod Health; 2017 Jun; 14(1):70. PubMed ID: 28595627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
